Zobrazeno 1 - 10
of 137
pro vyhledávání: '"Justin M. Watts"'
Publikováno v:
HemaSphere, Vol 7, p e810173a (2023)
Externí odkaz:
https://doaj.org/article/d895a73bdd4b46179943abbbe9461a72
Publikováno v:
HemaSphere, Vol 7, p e14426d1 (2023)
Externí odkaz:
https://doaj.org/article/22c84fd0cbb84c468f2a2fd015e33b38
Autor:
Courtney Dinardo, Gail Roboz, Justin M. Watts, Yazan Madanat, Gabrielle T Prince, Praneeth Baratam, Stéphane de Botton, Anthony Stein, James M Foran, Martha L Arellano, David Sallman, Dylan M Marchione, Xiaofei Bai, Prapti A Patel, Stephanie M Kapsalis, Guillermo Garcia-Manero, Amir Fathi
Publikováno v:
HemaSphere, Vol 7, p e75740ab (2023)
Externí odkaz:
https://doaj.org/article/ef75106ce8e24f1e977196cb95926e51
Autor:
Justin M. Watts, Anthony M. Hunter, Alessandra Iurlo, Blanca Xicoy, Francesca Palandri, Brandi Reeves, Alessandro Vannucchi, Prithviraj Bose, Rosa Ayala Diaz, Anna B. Halpern, Xuejun Chen, Francis Seguy, Feng Zhou, Fred Zheng, Pankit Vachhani
Publikováno v:
HemaSphere, Vol 7, p e1792906 (2023)
Externí odkaz:
https://doaj.org/article/701a01ff7dea43e6b160800d08dc06e1
Publikováno v:
Cancers, Vol 12, Iss 11, p 3225 (2020)
Acute myeloid leukemia (AML) is a genetically heterogeneous malignancy comprised of various cytogenetic and molecular abnormalities that has notoriously been difficult to treat with an overall poor prognosis. For decades, treatment options were limit
Externí odkaz:
https://doaj.org/article/0d41531b0a9540bbb6cb301d3e70c7d2
Autor:
Fatih M. Uckun, Christopher R. Cogle, Tara L. Lin, Sanjive Qazi, Vuong N. Trieu, Gary Schiller, Justin M. Watts
Publikováno v:
Cancers, Vol 12, Iss 1, p 74 (2019)
Combretastatin A1 (OXi4503) is a dual-function drug with vascular disrupting and cytotoxic properties that has exhibited single-agent anti-leukemia activity in murine xenograft models of acute myeloid leukemia (AML) and in a prior Phase 1A clinical s
Externí odkaz:
https://doaj.org/article/eda5f9f41d1a41babbe1af333db34c5b
Autor:
Justin M. Watts, Aymee Perez, Lutecia Pereira, Yao-Shan Fan, Geoffrey Brown, Francisco Vega, Kevin Petrie, Ronan T. Swords, Arthur Zelent
Publikováno v:
International Journal of Molecular Sciences, Vol 18, Iss 7, p 1492 (2017)
Here we report the case of a 30-year-old woman with relapsed acute myeloid leukemia (AML) who was treated with all-trans retinoic acid (ATRA) as part of investigational therapy (NCT02273102). The patient died from rapid disease progression following
Externí odkaz:
https://doaj.org/article/6c066e1e00e841ee9ec37524817da81c
Autor:
Sangeetha Venugopal, Justin M Watts
Publikováno v:
Blood Advances.
The discovery of isocitrate dehydrogenase 1 (IDH1) mutations in acute myeloid leukemia (AML) and the resounding success of molecularly targeted therapies in related myeloid malignancies swiftly prompted the development of IDH1mut inhibitors. Olutasid
Autor:
Brian A. Jonas, Jing‐Zhou Hou, Gail J. Roboz, Caroline L. Alvares, Deepa Jeyakumar, John R. Edwards, Harry P. Erba, Richard J. Kelly, Christoph Röllig, Walter Fiedler, Deanna Brackman, Satya R. Siddani, Brenda Chyla, Jacqueline Hilger‐Rolfe, Justin M. Watts
Publikováno v:
Hematological Oncology.
Autor:
Justin M. Watts, Ronan T. Swords, Ramin Shiekhattar, Luisa Cimmino, Lluis Morey, Arthur Zelent, Aymee Perez, Yvonne Dinh, Charles Chen, Amber Thomassen, Terrence J. Bradley, Deukwoo Kwon, Helena G. Dos Santos, Mina M. Tayari
Table S5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6654a9382cb00a2610ee5b1fd96baa7e
https://doi.org/10.1158/1078-0432.22481357.v1
https://doi.org/10.1158/1078-0432.22481357.v1